These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 23112323)
1. Medicine. Can intellectual property save drug development? FitzGerald GA Science; 2012 Oct; 338(6106):483-4. PubMed ID: 23112323 [No Abstract] [Full Text] [Related]
2. Open innovation and intellectual property: time for a reboot? Judd DB Drug Discov Today; 2013 Oct; 18(19-20):907-9. PubMed ID: 23958455 [No Abstract] [Full Text] [Related]
3. Industry and regulatory performance in 2012: a year in review. Dowden HM; Jahn R; Catka T; Jonsson A; Michael E; Miwa Y; Zinkand W Clin Pharmacol Ther; 2013 Sep; 94(3):359-66. PubMed ID: 23657160 [TBL] [Abstract][Full Text] [Related]
4. Re-engineering drug discovery and development. FitzGerald GA LDI Issue Brief; 2011 Oct; 17(2):1-4. PubMed ID: 22049582 [TBL] [Abstract][Full Text] [Related]
5. Raising the bar for market authorisation of new drugs. Naci H; Cylus J; Vandoros S; Sato A; Perampaladas K BMJ; 2012 Aug; 345():e4261. PubMed ID: 22872693 [No Abstract] [Full Text] [Related]
6. Overcoming the obstacles in the pharma/biotech industry: 2008 update. Graul AI; Revel L; Rosa E; Cruces E Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298 [TBL] [Abstract][Full Text] [Related]
7. The GAIN Act legislation to combat antimicrobial resistance: Where do we stand? Sfeir MM Infect Control Hosp Epidemiol; 2018 Dec; 39(12):1499-1500. PubMed ID: 30334503 [No Abstract] [Full Text] [Related]
8. Can open-source drug R&D repower pharmaceutical innovation? Munos B Clin Pharmacol Ther; 2010 May; 87(5):534-6. PubMed ID: 20407458 [TBL] [Abstract][Full Text] [Related]
9. The current state of drug discovery and what it might take to improve drug discovery outcomes and approval successes. Turner MJ Drug Discov Today; 2015 Aug; 20(8):917-9. PubMed ID: 26100736 [No Abstract] [Full Text] [Related]
10. Examining Manufacturing Readiness for Breakthrough Drug Development. Dye E; Sturgess A; Maheshwari G; May K; Ruegger C; Ramesh U; Tan H; Cockerill K; Groskoph J; Lacana E; Lee S; Miksinski SP AAPS PharmSciTech; 2016 Jun; 17(3):529-38. PubMed ID: 26608693 [No Abstract] [Full Text] [Related]
12. Drug-diagnostic co-development: how to harness the value. Blair ED; Blakemore JA Drug Discov Today; 2011 Oct; 16(19-20):902-5. PubMed ID: 21888987 [TBL] [Abstract][Full Text] [Related]
13. Medicines for tropical diseases; support through tax-incentives. John JE Drug Discov Today; 2011 Feb; 16(3-4):91-2. PubMed ID: 21111059 [No Abstract] [Full Text] [Related]
14. China spurs pharma innovation. Hughes B Nat Rev Drug Discov; 2010 Aug; 9(8):581-2. PubMed ID: 20671751 [No Abstract] [Full Text] [Related]
15. Biomedicine. Pharma firms push for sharing of cancer trial data. Bhattacharjee Y Science; 2012 Oct; 338(6103):29. PubMed ID: 23042862 [No Abstract] [Full Text] [Related]
16. Fix the antibiotics pipeline. Cooper MA; Shlaes D Nature; 2011 Apr; 472(7341):32. PubMed ID: 21475175 [No Abstract] [Full Text] [Related]
17. Ask the experts: future of the pharmaceutical industry. Interview by Future Medicinal Chemistry. Cottens S; Eaton M; Fuhr J; Geary S; Johnson DS; Li G; Raveglia L; Robertson GM; Westwell A Future Med Chem; 2011 Nov; 3(15):1863-72. PubMed ID: 22023030 [TBL] [Abstract][Full Text] [Related]
18. Extend data exclusivity to save drug development. Colca JR Science; 2013 Jan; 339(6118):393. PubMed ID: 23349271 [No Abstract] [Full Text] [Related]
19. Strategic R&D transactions in personalized drug development. Makino T; Lim Y; Kodama K Drug Discov Today; 2018 Jul; 23(7):1334-1339. PubMed ID: 29574213 [TBL] [Abstract][Full Text] [Related]
20. Impact of economic, regulatory, and patent policies on innovation in cancer chemoprevention. Grabowski HG; Moe JL Cancer Prev Res (Phila); 2008 Jul; 1(2):84-90. PubMed ID: 19138940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]